In essence, our data indicate that TRAF3IP2 is a tumor-derived factor that is important for tumor progression in NONO-TFE3 tRCC, uncovering a new regulatory mechanism that drives tumor progression. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.